COVID-19 Vaccination for Patients with Severe Alpha-1 Antitrypsin Deficiency

MLA

O. Mcelvaney, et al. “COVID-19 Vaccination for Patients with Severe Alpha-1 Antitrypsin Deficiency.” C41. ALPHA-1 ANTITRYPSIN DEFICIENCY, May 2022. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4119.

APA

O. Mcelvaney, D. Fraughen, G. Kelly, O.F. Mcelvaney, M. Herron, M.P. Murphy, T.P. Carroll, & N.G. Mcelvaney. (2022). COVID-19 Vaccination for Patients with Severe Alpha-1 Antitrypsin Deficiency. C41. ALPHA-1 ANTITRYPSIN DEFICIENCY. https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4119

Chicago

O. Mcelvaney, D. Fraughen, G. Kelly, O.F. Mcelvaney, M. Herron, M.P. Murphy, T.P. Carroll, and N.G. Mcelvaney. 2022. “COVID-19 Vaccination for Patients with Severe Alpha-1 Antitrypsin Deficiency.” C41. ALPHA-1 ANTITRYPSIN DEFICIENCY, May. doi:10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4119.